Probing binding determinants in center P of the cytochrome bc1 complex using novel hydroxy-naphthoquinones

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1797, Issue 1, 2010, Pages 38-43

  Hughes, Louise M ^a   Covian, Raul ^a   Gribble, Gordon W ^b   Trumpower, Bernard L ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b Lamont Doherty Earth Observatory   (United States)

Author keywords

Atovaquone; Cytochrome bc1 complex; Hydroxy naphthoquinones; Malaria; Plasmodium; Pneumocystis

Indexed keywords

2 HYDROXY 3 (2 ME OCTYL) 8 ME NAPHTHOQUINONE; 2 HYDROXY 3 (2 ME TRIFLUOROOCTYL) 8 ME NAPHTHOQUINONE; 2 HYDROXY 3 (2 ME TRIFLUOROOCTYL)NAPHTHOQUINONE; 2 HYDROXYNAPHTHOQUINONE DERIVATIVE; ATOVAQUONE; IRON SULFUR PROTEIN; NAPHTHOQUINONE; S 10576; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME BINDING; HUMAN; MOLECULAR MODEL; MOLECULAR PROBE; NONHUMAN; PLASMODIUM FALCIPARUM; PNEUMOCYSTIS; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

ANIMALS; ANTIMALARIALS; ATOVAQUONE; CATTLE; CYTOCHROMES B; ELECTRON TRANSPORT COMPLEX III; HUMANS; KINETICS; MALARIA; NAPHTHOQUINONES; PLASMODIUM FALCIPARUM; PNEUMOCYSTIS;

BOVINAE; PLASMODIUM FALCIPARUM; PNEUMOCYSTIS;

EID: 71749088377     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbabio.2009.07.010     Document Type: Article

References (30)

1. Vaidya A.B., and Mather M.W. Atovaquone resistance in malaria parasites. Drug Resist. Update 3 (2000) 283-287
2. 1 complex. J. Biol. Chem. 278 (2003) 31312-31318
3. Mather M.W., Darrouzet E., Valkova-Valchanova M., Cooley J.W., McIntosh M.T., Daldal F., and Vaidya A.B. Uncovering the molecular mode of action of the antimalarial drug atovaquone using a bacterial system. J. Biol. Chem. 280 (2005) 27458-27465
4. Srivastava I.K., Morrisey J.M., Darrouzet E., Daldal F., and Vaidya A.B. Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites. Mol. Microbiol. 33 (1999) 704-711
5. 1 complex and confer anti-malarial drug resistance in Saccharomyces cerevisiae. J. Biol. Chem. 280 (2005) 17142-17148
6. 1 complex inhibitors. FEMS Yeast Res. 8 (2008) 183-192
7. 1 complex. Biochim. Biophys. Acta 1767 (2007) 319-326
8. Fieser L.F., Chang F.C., Dauben W.G., Heidelberger C., Heymann H., and Seligman A.M. Naphthoquinone antimalarials. Metabolic oxidation products. J. Pharmacol. Exp. Ther. 94 (1948) 85-96
9. Hudson A.T., Dickins M., Ginger C.D., Gutteridge W.E., Holdich T., Hutchinson D.B.A., Pudney M., Randall A.W., and Latter V.S. 566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients. Drugs Exp. Clin. Res. 17 (1991) 427-435
10. Muller K., Faeh C., and Diederich F. Fluorine in pharmaceuticals: looking beyond intuition. Science 317 (2007) 1881-1886
11. Moody C.J., and Norton C.L. Synthesis of 1, 2-fused indoles by radical cyclisation. J. Chem. Soc., Perkin Trans. 1 17 (1997) 2639-2643
12. Mori K. Revision of the absolute configuration of A-factor. Tetrahedron 39 (1983) 3107-3109
13. Shirai S., Seki M., and Mori K. Pheromone synthesis, CXCIX. Eur. J. Org. Chem. (1999) 3139-3145
14. Gallardo H., and Merlo A.A. Ethyl lactate as a convenient precursor for synthesis of chiral liquid crystals. Synthetic Comm. 23 (1993) 2159-2169
15. Fouquet C., and Schlosser M. Improved carbon-carbon linking by controlled copper catalysis. Angew. Chem. 13 (1974) 83-84
16. Parker K.A., Spero D.M., and Koziski K.A. Assignment of regiochemistry to substituted naphthoquinones by chemical and spectroscopic method. J. Org. Chem. 52 (1986) 183-188
17. Guzikowski A.P., Cai S.X., Espitia S.A., Hawkinson J.E., Huettner J.E., Nogales D., Tran M., Woodward R.M., Weber E., and Keana J.F.W. Analogs of 3-hydroxy-1H-1-benzazepine-2, 5-dione: structure-activity relationship at N-methyl-d-aspartate receptor glycine sites. J. Med. Chem. 39 (1996) 4643-4653
18. 1 complexes from phylogenetically diverse species by a single chromatographic procedure. Biochim. Biophys. Acta 891 (1987) 227-242
19. 1 complex. J. Biol. Chem. 274 (1999) 31209-31216
20. 1 complexes containing the site-directed mutants of the Rieske iron-sulfur protein. Biochim. Biophys. Acta 1365 (1998) 125-134
21. 1. J. Biol. Chem. 247 (1972) 1012-1019
22. Berden J.A., and Slater E.C. The reaction of antimycin with a cytochrome b preparation active in reconstitution of the respiratory chain. Biochim. Biophys. Acta 216 (1970) 237-249
23. 1 complex from the yeast Saccharomyces cerevisiae co-crystallized with an antibody Fv fragment. Structure 8 (2000) 669-684
24. o site inhibitor bound. J. Biol. Chem. 278 (2003) 31303-31311
25. Krause P.J., Lepore T., Sikand V.K., Gadbaw Jr. J., Burke G., Telford III S.R., Brassard P., Pearl D., Azlanzadeh J., Christianson D., McGrath D., and Spielman A. Atovaquone and azithromycin for the treatment of babesiosis. N. Engl. J. Med. 343 (2000) 1454-1458
26. 1 complex is independent of the Rieske protein redox state. Consequences for semiquinone stabilization in the quinol oxidation site. J. Biol. Chem. 277 (2002) 48449-48455
27. 1 complex. J. Mol. Biol. 368 (2007) 197-208
28. Winter R.W., Kelly J.X., Smilkstein M.J., Dodean R., Bagby G.C., Rathbun R.K., Levin J.I., Hinrichs D., and Riscoe M.K. Evaluation and lead optimization of anti-malarial acridones. Exp. Parasitol. 114 (2006) 47-56
29. Baramee A., Coppin A., Mortuaire M., Pelinski L., Tomavo S., and Brocard J. Synthesis and in vitro activities of ferrocenic aminohydroxynaphthoquinones against Toxoplasma gondii and Plasmodium falciparum. Bioorg. Med. Chem. 14 (2006) 1294-1302
30. Hagmann W.K. The many roles for fluorine in medicinal chemistry. J. Med. Chem. 51 (2008) 4359-4369